Capital Fund Management S.A. raised its stake in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 232.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 90,681 shares of the company's stock after purchasing an additional 63,422 shares during the period. Capital Fund Management S.A. owned 0.16% of Molina Healthcare worth $26,393,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Wellington Management Group LLP boosted its holdings in Molina Healthcare by 7.4% during the fourth quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock worth $766,111,000 after buying an additional 181,073 shares during the last quarter. FMR LLC increased its position in shares of Molina Healthcare by 31.1% during the 4th quarter. FMR LLC now owns 1,801,113 shares of the company's stock worth $524,214,000 after purchasing an additional 427,276 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Molina Healthcare by 2.5% during the 4th quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock worth $417,144,000 after purchasing an additional 34,992 shares during the last quarter. Invesco Ltd. boosted its stake in shares of Molina Healthcare by 28.5% during the 4th quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock worth $386,229,000 after acquiring an additional 294,180 shares during the period. Finally, Norges Bank bought a new stake in shares of Molina Healthcare during the 4th quarter worth about $134,675,000. Institutional investors own 98.50% of the company's stock.
Molina Healthcare Stock Up 0.4 %
NYSE MOH traded up $1.22 during trading on Wednesday, reaching $336.72. 421,712 shares of the company's stock were exchanged, compared to its average volume of 652,601. The stock has a market cap of $18.42 billion, a P/E ratio of 16.48, a price-to-earnings-growth ratio of 1.06 and a beta of 0.70. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $373.22. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The company has a 50 day moving average price of $312.03 and a two-hundred day moving average price of $308.21.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing analysts' consensus estimates of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. On average, equities research analysts anticipate that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.
Insider Activity at Molina Healthcare
In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the transaction, the director now owns 17,375 shares in the company, valued at $5,235,608.75. This represents a 5.44 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.26% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on MOH. UBS Group reduced their target price on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a report on Friday, February 7th. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $350.00 price target (down from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. StockNews.com upgraded shares of Molina Healthcare from a "hold" rating to a "buy" rating in a research note on Friday, April 11th. Guggenheim assumed coverage on shares of Molina Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating for the company. Finally, Baird R W lowered shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday. Nine research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $359.42.
Read Our Latest Stock Report on Molina Healthcare
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
